MIST – milestone pharmaceuticals inc. - common shares (US:NASDAQ)
Stock Stats
News
4/11
05:32 am
mist
Low
Milestone Pharmaceuticals (MIST) was upgraded by Raymond James Financial, Inc. to "strong-buy".
4/10
09:00 am
mist
Low
Milestone Pharmaceuticals (MIST) is now covered by Raymond James Financial, Inc.. They set a "strong-buy" rating and a $6.00 price target on the stock.
4/10
08:00 am
mist
Medium
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
4/7
08:30 am
mist
Low
Milestone Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
4/2
08:00 am
mist
Medium
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/20/2026
07:12 am
mist
-19.5%
MISS
11/12/2025
07:01 am
mist
0.0%
BEAT
8/12/2025
07:05 am
mist
0.7%
MISS
5/14/2025
07:04 am
mist
-0.8%
MISS
4/11
05:32 am
Upgrades
Strong-Buy
Raymond James Financial, Inc.
Low
-2.0%
4/10
09:00 am
Initiates
Strong-Buy
Raymond James Financial, Inc.
Low
-1.0%
4/10
05:33 am
Initiates
STRONG BUY
RAYMOND JAMES
Low
-1.3%
4/10
05:33 am
Initiates
STRONG BUY
RAYMOND JAMES
Low
-1.3%
4/9
04:30 pm
Initiates
STRONG BUY
RAYMOND JAMES
Medium
-3.4%
4/16
04:12 pm
mist
Low
Form 144 Milestone Pharmaceutical Filed by: Oliveto Joseph
3/26
05:37 pm
mist
High
Form SCHEDULE 13G/A Milestone Pharmaceutical Filed by: Trails Edge Capital Partners, LP
3/23
06:51 pm
mist
Medium
Form 3 Milestone Pharmaceutical For: Mar 17 Filed by: Sandoval David I.
3/20
07:25 am
mist
High
Form 8-K Milestone Pharmaceutical For: Mar 20
3/20
07:08 am
mist
High
Form 10-K Milestone Pharmaceutical For: Dec 31
Show more
Top News Gainers
4/3 Form SC 13G/A Milestone Pharmaceutical Filed by: Venrock Healthcare Capital Partners II, L.P. 19.2%
5/9 Form 4 Milestone Pharmaceutical For: May 09 Filed by: RTW INVESTMENTS, LP 17.1%
3/6 Q4/2019 12/31/2019 EPS -0.750 ZacksConsensus -0.520 ActVsEst (0.230) - Miss 11.6%
1/2 Form 4 Milestone Pharmaceutical For: Dec 30 Filed by: WONG RODERICK 10.4%
3/24 Milestone Pharmaceuticals Inc. (NASDAQ: MIST) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. 8.3%
5/24 Form 8-K Milestone Pharmaceutical For: May 24 7.8%
7/8 Milestone Pharmaceuticals: Interesting, But Not Well-Differentiated From Generic Competition [Seeking Alpha] 7.8%
2/5 Milestone Pharmaceuticals Inc. (NASDAQ: MIST) had its "buy" rating re-affirmed by analysts at Piper Sandler. They now have a $26.50 price target on the stock. 5.9%
5/21 Milestone Pharmaceuticals Presents Studies on the Economic Impacts of PSVT at the ISPOR 2019 Annual Meeting 5.7%
1/13 Form 4 Milestone Pharmaceutical For: Jan 13 Filed by: RTW INVESTMENTS, LP 5.6%
Top News Decliners
3/23 Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment -87.1%
3/12 Form SC 13D/A Milestone Pharmaceutical Filed by: Novo Holdings A/S -8.4%
3/19 Form 4 Milestone Pharmaceutical For: Mar 02 Filed by: RTW INVESTMENTS, LP -7.3%
6/7 Milestone Pharmaceuticals (MIST) Presents At 2019 Jefferies Global Healthcare Conference - Slideshow [Seeking Alpha] -6.1%
11/8 Milestone Pharmaceuticals Inc. (NASDAQ: MIST) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.9%
5/15 Form 8-K Milestone Pharmaceutical For: May 13 -3.9%
3/6 Form S-8 Milestone Pharmaceutical -3.8%
6/3 Milestone Pharmaceuticals Inc. (NASDAQ: MIST) is now covered by analysts at Cowen Inc. They set a "buy" rating and a $32.00 price target on the stock. -3.3%
11/14 Milestone Pharmaceuticals to Present at Upcoming Investor Conferences -2.9%
10/3 Form 4 Milestone Pharmaceutical For: Oct 01 Filed by: RTW INVESTMENTS, LP -2.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3